• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tumour Expression of Histone Deacetylases in Uveal Melanoma.葡萄膜黑色素瘤中组蛋白去乙酰化酶的肿瘤表达
Ocul Oncol Pathol. 2019 Apr;5(3):153-161. doi: 10.1159/000490038. Epub 2018 Sep 18.
2
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence.组蛋白去乙酰化酶抑制剂在葡萄膜黑色素瘤中的作用:当前证据
Anticancer Res. 2018 Jul;38(7):3817-3824. doi: 10.21873/anticanres.12665.
3
Novel mouse model for primary uveal melanoma: a pilot study.原发性葡萄膜黑色素瘤的新型小鼠模型:一项初步研究。
Clin Exp Ophthalmol. 2017 Mar;45(2):192-200. doi: 10.1111/ceo.12814. Epub 2016 Sep 7.
4
Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.葡萄膜黑色素瘤的肿瘤内空间异质性:具有侵袭潜能的肿瘤细胞亚型表现出特定的表观遗传学染色反应。
Exp Eye Res. 2019 May;182:175-181. doi: 10.1016/j.exer.2019.04.001. Epub 2019 Apr 4.
5
Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma.葡萄膜黑色素瘤患者核仁细胞形态评估的临床意义。
Anticancer Res. 2020 Jun;40(6):3505-3512. doi: 10.21873/anticanres.14338.
6
Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.葡萄膜黑色素瘤核 BRCA1 相关蛋白-1 免疫反应性是转移的指标。
Ophthalmology. 2018 Feb;125(2):203-209. doi: 10.1016/j.ophtha.2017.07.018. Epub 2017 Aug 18.
7
Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.血管内皮生长因子在葡萄膜黑色素瘤中的表达及其与转移的相关性。
Br J Ophthalmol. 2000 Jul;84(7):750-6. doi: 10.1136/bjo.84.7.750.
8
Diagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma.SOX-10免疫组织化学染色对葡萄膜黑色素瘤检测的诊断价值。
Ecancermedicalscience. 2015 Aug 20;9:566. doi: 10.3332/ecancer.2015.566. eCollection 2015.
9
Inhibitors of NAD+ dependent histone deacetylases (sirtuins).NAD⁺依赖性组蛋白去乙酰化酶(沉默调节蛋白)抑制剂。
Curr Pharm Des. 2008;14(6):562-73. doi: 10.2174/138161208783885380.
10
Expression of the metastasis suppressor BRMS1 in uveal melanoma.转移抑制因子BRMS1在葡萄膜黑色素瘤中的表达
Ecancermedicalscience. 2014 Mar 11;8:410. doi: 10.3332/ecancer.2014.410. eCollection 2014.

引用本文的文献

1
HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic.组蛋白去乙酰化酶/σ1受体双配体作为靶向性黑色素瘤治疗药物
Pharmaceuticals (Basel). 2025 Jan 28;18(2):179. doi: 10.3390/ph18020179.
2
Clinical Significance of the Immunohistochemical Expression of Histone Deacetylases (HDACs)-2, -4, and -5 in Ovarian Adenocarcinomas.组蛋白去乙酰化酶(HDACs)-2、-4和-5在卵巢腺癌中免疫组化表达的临床意义
Biomedicines. 2024 Apr 24;12(5):947. doi: 10.3390/biomedicines12050947.
3
Inhibiting the activation of MAPK (ERK1/2) in stressed Müller cells prevents photoreceptor degeneration.抑制应激状态下 Müller 细胞中 MAPK(ERK1/2)的激活可防止光感受器变性。
Theranostics. 2022 Sep 11;12(15):6705-6722. doi: 10.7150/thno.71038. eCollection 2022.
4
Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma.鉴定与葡萄膜黑色素瘤预后相关的 5 个 microRNA 生物标志物。
Medicine (Baltimore). 2022 Sep 2;101(35):e30366. doi: 10.1097/MD.0000000000030366.
5
Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma.评估组蛋白去乙酰化酶 6 抑制剂治疗原发性和转移性葡萄膜黑色素瘤的潜力。
Int J Mol Sci. 2022 Aug 19;23(16):9378. doi: 10.3390/ijms23169378.
6
Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor.组蛋白去乙酰化酶抑制剂瑞可利司他可抑制葡萄膜黑色素瘤细胞系的增殖。
Cancers (Basel). 2022 Feb 3;14(3):782. doi: 10.3390/cancers14030782.
7
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.葡萄膜黑色素瘤的预后生物标志物:现状、最新进展与未来方向
Cancers (Basel). 2021 Dec 25;14(1):96. doi: 10.3390/cancers14010096.
8
Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients' Survival.葡萄膜黑色素瘤中组蛋白去乙酰化酶(HDAC)-1、-2、-4和-6:与临床病理参数及患者生存的关联
Cancers (Basel). 2021 Sep 23;13(19):4763. doi: 10.3390/cancers13194763.
9
Haloperidol Metabolite II Valproate Ester ()-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma.氟哌啶醇代谢产物 II 丙戊酸酯 ()-(-)-MRJF22:作为一种潜在的多用途药物治疗葡萄膜黑色素瘤的初步研究。
J Med Chem. 2021 Sep 23;64(18):13622-13632. doi: 10.1021/acs.jmedchem.1c00995. Epub 2021 Sep 3.
10
Current molecular and clinical insights into uveal melanoma (Review).当前对葡萄膜黑色素瘤的分子和临床认识(综述)。
Int J Oncol. 2021 Apr;58(4). doi: 10.3892/ijo.2021.5190. Epub 2021 Mar 2.

本文引用的文献

1
Racial Differences in the Extracellular Matrix and Histone Acetylation of the Lamina Cribrosa and Peripapillary Sclera.筛板和视乳头周围巩膜的细胞外基质及组蛋白乙酰化的种族差异
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4143-4154. doi: 10.1167/iovs.17-21474.
2
Prolactin protects retinal pigment epithelium by inhibiting sirtuin 2-dependent cell death.催乳素通过抑制依赖沉默调节蛋白2的细胞死亡来保护视网膜色素上皮。
EBioMedicine. 2016 May;7:35-49. doi: 10.1016/j.ebiom.2016.03.048. Epub 2016 Apr 20.
3
Ultraviolet-B induces ERCC6 repression in lens epithelium cells of age-related nuclear cataract through coordinated DNA hypermethylation and histone deacetylation.紫外线B通过协同的DNA高甲基化和组蛋白去乙酰化作用,诱导年龄相关性核性白内障晶状体上皮细胞中ERCC6基因表达受抑制。
Clin Epigenetics. 2016 May 26;8:62. doi: 10.1186/s13148-016-0229-y. eCollection 2016.
4
SIRT2 Expression Is Higher in Uveal Melanoma than In Ocular Melanocytes.葡萄膜黑色素瘤中SIRT2的表达高于眼黑色素细胞。
Ocul Oncol Pathol. 2015 Dec;2(2):100-4. doi: 10.1159/000439309. Epub 2015 Oct 17.
5
Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.III类特异性组蛋白去乙酰化酶抑制剂Tenovin-6可诱导葡萄膜黑色素瘤细胞凋亡、抑制其迁移并消除癌症干细胞。
Sci Rep. 2016 Mar 4;6:22622. doi: 10.1038/srep22622.
6
Upcoming translational challenges for uveal melanoma.葡萄膜黑色素瘤即将面临的转化医学挑战。
Br J Cancer. 2015 Nov 3;113(9):1249-53. doi: 10.1038/bjc.2015.269. Epub 2015 Oct 27.
7
Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain.人类额叶皮质、人类视网膜和小鼠大脑中组蛋白去乙酰化酶亚型的定量分析。
PLoS One. 2015 May 11;10(5):e0126592. doi: 10.1371/journal.pone.0126592. eCollection 2015.
8
Drug Combinations with HDAC Inhibitors in Antitumor Therapy.抗肿瘤治疗中与组蛋白去乙酰化酶抑制剂联用的药物组合
Crit Rev Oncog. 2015;20(1-2):83-117. doi: 10.1615/critrevoncog.2014012378.
9
Expression of SIRT2 and SIRT6 in retinoblastoma.视网膜母细胞瘤中SIRT2和SIRT6的表达
Ophthalmic Res. 2015;53(2):100-8. doi: 10.1159/000368718. Epub 2015 Feb 5.
10
Histone deacetylase inhibitors in hematological malignancies and solid tumors.血液系统恶性肿瘤和实体瘤中的组蛋白去乙酰化酶抑制剂
Arch Pharm Res. 2015 Jun;38(6):933-49. doi: 10.1007/s12272-015-0571-1. Epub 2015 Feb 5.

葡萄膜黑色素瘤中组蛋白去乙酰化酶的肿瘤表达

Tumour Expression of Histone Deacetylases in Uveal Melanoma.

作者信息

Levinzon Louis, Madigan Michele, Nguyen Vuong, Hasic Enisa, Conway Max, Cherepanoff Svetlana

机构信息

Save Site Institute, Sydney Medical School, The University of Sydney, Sydney Eye Hospital, Sydney, New South Wales, Australia.

出版信息

Ocul Oncol Pathol. 2019 Apr;5(3):153-161. doi: 10.1159/000490038. Epub 2018 Sep 18.

DOI:10.1159/000490038
PMID:31049320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6489079/
Abstract

PURPOSE

To determine the expression of histone deacetylase enzymes in uveal melanoma tumour cells.

PROCEDURES

This is an observational immunohistochemical study of 16 formalin-fixed, paraffin-embedded eyes enucleated for uveal melanoma between January 2001 and March 2002. Haematoxylin and eosin paraffin sections were reviewed for histopathological parameters according to the American Joint Committee on Cancer 7th edition. Sections were then immunohistochemically stained for histone deacetylases 1, 2, 3, 4 and 6 and sirtuin 2 using an automated Leica Bond II platform and Fast Red chromogen, then digitally scanned using Aperio software before assessment of staining.

RESULTS

Nuclear expression of histone deacetylases 1, 2, 3, 4 and 6 and of sirtuin 2 was confirmed in uveal melanoma tumour cells. In addition, the tumour cells showed cytoplasmic expression of histone deacetylases 4 and 6 and sirtuin 2. Nuclear and cytoplasmic immunostaining was also seen in intraocular tissues uninvolved by the tumour.

CONCLUSION

Uveal melanoma tumour cells express histone deacetylases 1, 2, 3, 4 and 6 and sirtuin 2, confirming potential tissue targets for histone deacetylase inhibitors.

摘要

目的

确定组蛋白去乙酰化酶在葡萄膜黑色素瘤肿瘤细胞中的表达。

程序

这是一项观察性免疫组织化学研究,研究对象为2001年1月至2002年3月间因葡萄膜黑色素瘤而摘除的16只经福尔马林固定、石蜡包埋的眼睛。根据美国癌症联合委员会第7版对苏木精和伊红石蜡切片进行组织病理学参数评估。然后使用自动徕卡Bond II平台和固红显色剂对切片进行组蛋白去乙酰化酶1、2、3、4和6以及沉默调节蛋白2的免疫组织化学染色,在评估染色之前使用Aperio软件进行数字扫描。

结果

在葡萄膜黑色素瘤肿瘤细胞中证实了组蛋白去乙酰化酶1、2、3、4和6以及沉默调节蛋白2的核表达。此外,肿瘤细胞显示组蛋白去乙酰化酶4和6以及沉默调节蛋白2的细胞质表达。在未受肿瘤累及的眼内组织中也可见核和细胞质免疫染色。

结论

葡萄膜黑色素瘤肿瘤细胞表达组蛋白去乙酰化酶1、2、3、4和6以及沉默调节蛋白2,证实了组蛋白去乙酰化酶抑制剂的潜在组织靶点。